Revisiting safety of minocycline as neuroprotection in Huntington's disease.
Reynolds
Norman
N
D000293:Adolescent; D000328:Adult; D000368:Aged; D000900:Anti-Bacterial Agents / Q000009:adverse effects* / Q000627:therapeutic use*; D006801:Humans; D006816:Huntington Disease / Q000188:drug therapy*; D017495:Hyperpigmentation / Q000139:chemically induced* / Q000453:epidemiology; D008875:Middle Aged; D008911:Minocycline / Q000009:adverse effects* / Q000627:therapeutic use*; D018696:Neuroprotective Agents / Q000009:adverse effects* / Q000627:therapeutic use*; D015995:Prevalence
D000900:Anti-Bacterial Agents; D018696:Neuroprotective Agents; D008911:Minocycline